Healthcare group, Stirling Products Limited (ASX:STI) advises that a paper on the Company’s unique HDA pulmonary Drug Delivery devices is featured in this months specialist ONdrugDelivery publication on Pulmonary and Nasal Drug Delivery.
The issue is sponsored by 3M Company and is to be distributed to all attendees at the Respiratory Drug Delivery Conference being held in Berlin over four days this week as well coverage to a readership base of approximately 40,000 worldwide largely within the pharmaceutical and biotechnology industry sectors. The publication can be accessed at the Stirling Products or ONdrugDelivery.com websites.
For further information please download PDF below:
